Polychondritis, Relapsing: Clinical Trials

2 trials for Polychondritis, Relapsing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Polychondritis, Relapsing: new trials by email Literature Review of Polychondritis, Relapsing trials Research Report on Polychondritis, Relapsing

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Upadacitinib, corticosteroids and immunosuppressants - Relapsing Polychondritis
Phase 1 / Phase 2RecruitingPeking University People's Hospital302024-11-152025-03-12
Study on the Safety of Abatacept in Relapsing Polychondritis
Abatacept - Relapsing Polychondritis
Phase 1CompletedBenaroya Research Institute42011-01-012012-08-07

Broader conditions

Cartilage Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Abatacept (1)  ·  Adrenal Cortex Hormones (1)  ·  Immunosuppressive Agents (1)  ·  upadacitinib (1)

Sponsors

Benaroya Research Institute (1)  ·  Peking University People's Hospital (1)

Countries

China (1)  ·  United States (1)

Top investigators

Zhanguo Li (1)

Results publications

PMID 23606702